Composition
- Active ingredients
- DEURUXOLITINIB PHOSPHATE EQ 8MG BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA217900.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Leqselvi
- Active substance
- deuruxolitinib phosphate
- Drug class
- Janus-associated kinase (JAK) inhibitors
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Sun Pharm Inds Inc
- Status
- Prescription
- FDA approval
- 25 Jul 2024
- Application
- NDA217900-001